# A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Source: https://onco.cc/trials/nct07114315/  
OnCo record `nct07114315` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of AK112 in pancreatic ductal adenocarcinoma, run by Akeso, now recruiting.

## Summary

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer is a phase 2 interventional study registered as NCT07114315 by Akeso, with 160 participants planned, started 2025-09-19 and due to reach its primary completion in 2027-08. Interventions recorded: AK112 and AK130.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07114315
- Phase: 2
- Setting: A Phase II Clinical Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
- Sponsor: Akeso
- Enrolled: 160

## Sources

- ClinicalTrials.gov NCT07114315: https://clinicaltrials.gov/study/NCT07114315

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- companies: [Akeso](https://onco.cc/companies/akeso/)

---
JSON: https://onco.cc/api/v1/entities/nct07114315.json